Company
Adherium Limited
Headquarters: Auckland, New Zealand
Market Cap
A$20.7 Million
AUD as of Jan. 1, 2024
US$14.1 Million
Adherium Limited Categories
New Zealand Healthcare Medical DevicesNew Zealand Healthcare New Zealand Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. The company offers Hailie, an asthma and COPD medication adherence solution for patients with chronic respiratory diseases. It also provides smart device sensors for respiratory medications, such as Bluetooth enabled Hailie sensors wrap around a patient's existing inhalers and automatically send usage data to their smartphone; and Hailie app that enables patients, caregivers, and healthcare professionals to track medication adherence, set daily reminders, into their medication usage. In addition, the company offers digital health solutions to patients, pharmaceutical companies, healthcare providers, and contract research organizations. The company was incorporated in 2001 and is headquartered in Auckland, New Zealand.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Adherium Limited has the following listings and related stock indices.
Stock: ASX: ADR wb_incandescent